Phenylbutazone: back on the French market: reappearance. A NSAID to avoid. Life-threatening toxicity.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D017277:Drug Approval; D005602:France; D006801:Humans; D009140:Musculoskeletal Diseases / Q000188:drug therapy; D010653:Phenylbutazone / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010653:Phenylbutazone